In view of the pathophysiology of MPN, this points to the involvement of both Jak2+/+ and Jak2VF/+ cells in the development of the pro-inflammatory situation in JAK2-VF-positive disease. This evidence concerns the gene JAK2 and myeloproliferative disorder.